Moleculin Biotech Inc — Cash Flow (NASDAQ:MBRX) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics

Quarterly Annual

Cash from operating activities 17.8 M19 M27.6 M24.1 M23.86 M 22.45 M Cash from investing activities 374 K19 K67 K124 K13 K 0 Cash from financing activities 22.55 M74.72 M23 K4.65 M4.63 M 19.8 M Free cash flow 17.42 M18.98 M27.53 M23.98 M23.85 M 22.45 M

Nachrichten

Moleculin Biotech releases CEO update on leukemia trial

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.54%

Moleculin Biotech: Aktie bricht nach Vereinbarung zur Optionsscheinausübung ein

Moleculin Biotech stock plunges after warrant exercise agreement

Moleculin Biotech sichert sich 8,3 Millionen US-Dollar durch Ausübung von Optionsscheinen

Moleculin Biotech raises $8.3 million through warrant exercise

Moleculin Biotech: Aktie legt nach vielversprechenden Studiendaten zu AML-Medikament zu

Moleculin Biotech stock rises as AML drug trial shows promising results

Moleculin: Positive erste Daten aus zulassungsrelevanter Studie zur AML-Behandlung

Moleculin reports promising early data in pivotal AML treatment trial

Moleculin Biotech: Aktie legt nach wichtiger Patenterteilung in Japan zu

Moleculin Biotech stock rises after securing key Japanese patent